Holen Sie sich die Stockscreener-App
654.80
0.35%
2.29
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$652.51
Offen:
$654.15
24-Stunden-Volumen:
1.66M
Relative Volume:
0.83
Marktkapitalisierung:
$242.11B
Einnahmen:
$45.20B
Nettoeinkommen (Verlust:
$6.87B
KGV:
36.00
EPS:
18.1888
Netto-Cashflow:
$6.75B
1W Leistung:
-2.99%
1M Leistung:
+7.60%
6M Leistung:
+33.24%
1J Leistung:
+24.73%
1-Tages-Spanne:
$648.29
$659.47
1-Wochen-Bereich:
$648.29
$683.63
52-Wochen-Spanne:
$435.27
$683.63
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, NTRA, A, IQV
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
654.80 | 241.26B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
214.06 | 157.81B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
410.35 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
167.78 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
258.21 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-09 | Hochstufung | UBS | Neutral → Buy |
| 2026-09-03 | Eingeleitet | CLSA | Outperform |
| 2026-06-26 | Fortgesetzt | Bernstein | Mkt Perform |
| 2026-06-11 | Eingeleitet | Piper Sandler | Neutral |
| 2026-06-03 | Herabstufung | HSBC Securities | Buy → Hold |
| 2026-06-02 | Fortgesetzt | Wolfe Research | Outperform |
| 2026-05-15 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2026-03-27 | Eingeleitet | DZ Bank | Buy |
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Thermo Fisher Scientific Inc. stock falls Thursday, underperforms market - MarketWatch
Thermo Fisher Scientific Inc Stock (TMO) Closed Down by 3.34% on Oct 1: What Signal Does It Send? - TradingKey
Global Liver Cancer Diagnostics Market to Observe Impressive Growth at a CAGR of ~9% by 2034 | DelveInsight - GlobeNewswire Inc.
Continuous Bioprocessing Technologies Market - GlobeNewswire Inc.
Thermo Fisher Scientific stock pre-market at EUR 598.30: plus 0.28 percent - AD HOC NEWS
Should CHO K1 Media Launch Require Action From Thermo Fisher Scientific Stock Investors? - Simply Wall Street
Thermo Fisher Scientific stock raises guidance and trades at EUR 596.90 - AD HOC NEWS
Thermo Fisher Scientific Inc (TMO) Stock Forecasts - Yahoo Finance
Thermo Fisher Scientific Inc (TMO) Stock Up 0.1% but GF Value Sa - GuruFocus
Thermo Fisher (TMO) director's deferred stock units total 2,846.55 after a quarterly credit - Stock Titan
At $675 per unit, a Thermo Fisher (TMO) director was credited with 62.96 stock units. - Stock Titan
Director Karen S. Lynch holds 398.7 deferred stock units at Thermo Fisher Scientific (TMO) after the credit. - Stock Titan
Thermo Fisher (TMO) credits director pay as stock units at $675 each. - Stock Titan
Thermo Fisher Scientific (NYSE:TMO) Stock: Faster Organic Growth Lifts Its 2026 Outlook - kalkine.ca
Thermo Fisher Scientific stock trades at EUR 596.90 before October 21 results - AD HOC NEWS
Thermo Fisher Scientific (TMO) Stock Seems Reasonable Following Its 47% Run - Yahoo Finance
Will Thermo Fisher’s New cGMP CHO-K1 Panel and MRD Moves Change Thermo Fisher Scientific's (TMO) Narrative - Yahoo Finance
Thermo Fisher Scientific stock last trades at USD 677.36 on September 28, 2026 - AD HOC NEWS
Thermo Fisher to Offer Evosep Eno Liquid Chromatography System - genomeweb.com
Veterinary Diagnostics Market Size to Soar to USD 30.78 Billion by 2035 at a CAGR of 10.1% - GlobeNewswire Inc.
Press Release: Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026 - Moomoo
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026 - Business Wire
Global Therapeutic Drug Monitoring Consumables Market Forecast, 2026-2032 - GlobeNewswire Inc.
Thermo Fisher Scientific and Evosep Enter Reseller Agreement for Evosep Eno - Yahoo Finance
Thermo Fisher Scientific stock at USD 675.00 on September 25, 2026 - AD HOC NEWS
Pfizer vs. Thermo Fisher: Which Healthcare Turnaround has More Upside? - Yahoo Finance
Thermo Fisher stock last at USD 670.38, down 1.18 percent in New York trading - AD HOC NEWS
Thermo Fisher Scientific's Building Blocks to 2028 Growth 'Fundamentally Sound,' Deutsche Bank Says - Yahoo Finance
Thermo Fisher Scientific Inc (CEUX:TN8d) Stock PDF (Updated: 2026/09/25) - GuruFocus
Thermo Fisher Scientific Inc Stock Warning Signs | CEUX:TN8d - GuruFocus
Here's How Much a $1000 Investment in Thermo Fisher Scientific Made 10 Years Ago Would Be Worth Today - Yahoo Finance
Thermo Fisher Scientific stock gains 1.97 percent near yearly high - AD HOC NEWS
What Is Changing for Thermo Fisher Scientific (NYSE:TMO)? - Kalkine Media
Thermo Fisher Scientific stock rises 1.64 percent ahead of the open - AD HOC NEWS
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Thermo Fisher Stock Hits Record High: What's Happening? - Benzinga
Dodge and Cox’s Bullish Stance on Thermo Fisher Scientific (TMO) - Yahoo Finance
Thermo Fisher Scientific stock hits 52-week high at 671.69 USD - Investing.com Canada
Thermo Fisher Scientific stock gains 1.03 percent on results - AD HOC NEWS
Biodesix Advances MRD Monitoring Programs With Bio-Rad and Thermo Fisher - Yahoo Finance
Biodesix advances MRD testing programs with Bio-Rad, Thermo Fisher - Investing.com
Thermo Fisher Scientific (TMO) Launches Gibco CHO K1 Panel On A Fair Value Question - Yahoo Finance
Biodesix Announces Progress on Tumor-Informed and Tumor-Naïve MRD Programs with Bio-Rad and Thermo Fisher - Quiver Quantitative
Thermo Fisher Scientific (TMO) Rolls Out New Media Panel For Biologics Development - Yahoo Finance
Thermo Fisher Scientific stock gains before the bell - AD HOC NEWS
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher Scientific stock gains at the close - AD HOC NEWS
Thermo Fisher, Bird, BRS at 52-Week Highs on News - baystreet.ca
Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development - BioSpace
Thermo Fisher launches CHO-K1 cell culture media panel By Investing.com - Investing.com Canada
Thermo Fisher Scientific stock holds near its yearly high - AD HOC NEWS
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.09%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):